![Zhen Su](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhen Su
Directeur/Membre du Conseil chez
KARYOPHARM THERAPEUTICS INC.
Fortune : - $ au 31/05/2026
Profil
Zhen Su is currently Chief Executive Officer & Director at Marengo Therapeutics, Inc. since 2021, Independent Director at Karyopharm Therapeutics, Inc. since 2023, and Independent Director at CytomX Therapeutics, Inc. since 2024.
Former roles include SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021, Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019, and Director-Cell & Gene Therapy Program at the University of Florida from 2006 to 2009.
Education includes an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 30/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Zhen Su
| Sociétés | Poste | Début |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Directeur/Membre du Conseil | 31/08/2023 |
| CYTOMX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/03/2024 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Directeur Général | 01/07/2021 |
Anciens postes connus de Zhen Su
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Directeur Technique/Scientifique/R&D | 01/01/2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Directeur Technique/Scientifique/R&D | 01/01/2019 |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2009 |
Formation de Zhen Su
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Dresden University of Technology
 Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
